1.3 Irish Healthcare System & Pharmacy Environment

1.3 Irish Healthcare System & Pharmacy Environment

System Overview: Pharmacy practice in Ireland operates within a dual public-private healthcare system structured by government policy, statutory regulations, state reimbursement schemes, and independent regulatory oversight.

To practice effectively in Ireland and excel in the PSI Equivalence Examination, candidates must thoroughly understand the regulatory agencies, funding mechanisms, operational structures, and legal frameworks governing Irish healthcare.

---

Governance Architecture: Department of Health & HSE

Irish healthcare administration is divided between policy formation and operational service delivery:

1. Department of Health (DoH)

The Department of Health is the executive government department responsible for formulation of national health policy, drafting healthcare legislation, allocating annual health budgets, and strategic health planning across Ireland.

2. Health Service Executive (HSE)

The Health Service Executive (HSE) is the statutory operational body responsible for delivering public health and personal social services across Ireland. Operational delivery is organized through regional structures (Regional Health Areas - RHAs) and Community Health Organisations (CHOs).

3. Primary Care Reimbursement Service (PCRS)

The PCRS is a specialized division within the HSE that manages the financial reimbursement and administration of primary care community schemes. Community pharmacies contract with the HSE PCRS to dispense medicines to eligible patients under state reimbursement schemes.

---

Primary Care Reimbursement Service (PCRS) State Schemes

Community pharmacy practice in Ireland is heavily centered around dispensing under PCRS community drug schemes. Understanding these schemes is vital for legal validation and patient consultation in Ireland:

---

Health Products Regulatory Authority (HPRA) Mandate

The Health Products Regulatory Authority (HPRA) (formerly the Irish Medicines Board - IMB) is the national competent authority regulating human and veterinary medicines, medical devices, blood components, cosmetics, and controlled substances in Ireland.

                         ┌──────────────────────────────┐
                         │   Health Products Regulatory  │
                         │       Authority (HPRA)       │
                         └──────────────┬───────────────┘
                                        │
     ┌──────────────────┬───────────────┴───────────────┬──────────────────┐
     ▼                  ▼                               ▼                  ▼
┌─────────┐        ┌─────────┐                     ┌─────────┐        ┌─────────┐
│Market   │        │Pharmaco-│                     │Good     │        │Controlled│
│Authoriz.│        │vigilance│                     │Distrib. │        │Substance│
│(MA/PA)  │        │& ADRs   │                     │Practice │        │Licensing│
└─────────┘        └─────────┘                     └─────────┘        └─────────┘

Key HPRA Functions

• Market Authorization (MA): Evaluating scientific data to grant Product Authorizations (PAs) or Dual Pack Authorizations (DPAs) for medicines sold in Ireland.
• Pharmacovigilance & Safety Alerts: Monitoring adverse drug reactions (ADRs), issuing drug recalls, safety notices, and Direct Healthcare Professional Communications (DHPCs).
• Inspection & Enforcement: Inspecting pharmaceutical manufacturers, wholesalers, and distributors to enforce Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP).
• Controlled Substance Licensing: Regulating import, export, and manufacture of controlled drugs under international conventions and Irish legislation.

---

Community Pharmacy Practice Landscape

There are approximately 1,900 community pharmacies in Ireland. Under the Pharmacy Act 2007, community pharmacies operate under strict statutory leadership rules:

Statutory Pharmacist Roles

• Superintendent Pharmacist: Holds overall statutory responsibility for the professional and clinical management of the pharmacy business, quality assurance systems, SOPs, and regulatory compliance across the pharmacy enterprise.
• Supervising Pharmacist: Holds day-to-day operational responsibility for a specific registered pharmacy premises. Must have a minimum of 3 years' post-registration experience. Ensures continuous personal supervision of dispensing activities during opening hours.

Expanded Community Pharmacy Services

Community pharmacists in Ireland deliver an expanding range of clinical primary care services:

1. Vaccination Services: Supply and administration of seasonal influenza, COVID-19, and pneumococcal vaccines under specific PSI training protocols and medicinal product regulations.
2. Emergency Hormonal Contraception (EHC): Non-prescription supply of Levonorgestrel or Ulipristal acetate directly by pharmacists following structured patient consultations.
3. Minor Ailment & OTC Triage: Recommending non-prescription medicines, health screening (blood pressure, lipid checks), and triage referral to primary care GPs.

---

Hospital Pharmacy Practice and Clinical Governance

Hospital pharmacy in Ireland operates within public acute hospital groups and private hospital facilities. Hospital pharmacists work as integral members of multidisciplinary clinical teams:

• Clinical Ward Pharmacy & Medicines Reconciliation: Auditing medication histories upon admission, performing daily chart reviews, optimizing dosages, and facilitating discharge counseling.
• Aseptic Compounding & Cytotoxics: Preparing sterile parenteral nutrition (TPN), central intravenous additions, and cytotoxic chemotherapy within cleanroom facilities.
• Antimicrobial Stewardship (AMS): Leading hospital AMS committees to monitor antibiotic usage, enforce restrictive formulary guidelines, and minimize healthcare-associated infections (HCAIs).
• Hospital Formularies & Drugs & Therapeutics Committees (DTC): Evaluating new medicine admissions to hospital formularies based on clinical efficacy and health technology assessment (HTA).

---

Legislative & Pricing Framework: Health Act 2013 and Reference Pricing

The Health (Pricing and Supply of Medical Goods) Act 2013 fundamentally altered medicine dispensing and pricing in Ireland:

• Generic Substitution: Empowers community pharmacists to substitute a prescribed brand-name medicine with a cheaper interchangeable generic equivalent listed on the HPRA Interchangeable List, unless the prescriber has explicitly marked "Do Not Substitute" on clinical grounds.
• Reference Pricing: The HSE establishes a maximum reimbursement price (reference price) for groups of interchangeable medicines. If a patient chooses a higher-priced brand, they pay the cost difference out-of-pocket.